CEFMAC TZ 562.5MG INJECTION is a combination of Ceftriaxone and Tazobactam which belongs to the group of medicines called Antibiotics. It is used to treat several bacterial infections like lower respiratory tract infections such as pneumonia, acute bacterial otitis media lower respiratory tract infections, pneumonia, infection in the ear, skin, urinary tract infections, gonorrhoea, pelvic inflammatory disease, bacterial septicaemia, bone and joint infections, intra-abdominal infections, including peritonitis and biliary tract infections, bacterial meningitis, surgical prophylaxis (pre-operative antibiotics, infections in neutropenic patients).
Pneumonia is an infection which causes inflammation in the air sac producing cough with phlegm and shortness of breath. Urinary tract infection affects the urinary bladder later gets spreads to the kidneys. Bacteraemia is an infectious condition indicating presence of bacteria in the blood stream. Bacterial meningitis is an infection caused by bacteria in the region surrounding the brain. Neutropenic is low levels of neutrophils (a type of white blood cells) in our body.
Inform your doctor or your health- care professional before any laboratory tests as CEFMAC TZ 562.5MG INJECTION will interact with medical investigations. Inform your doctor if you are allergic to any antibiotics or to any other medicines.
CEFMAC TZ 562.5MG INJECTION should not be used in patients allergic to penicillin antibiotics, cefepime, tazobactam and other beta-lactam antibiotics.
CEFMAC TZ 562.5MG INJECTION should be used with caution in patients with or history of allergic reactions, diarrhoea, gastrointestinal disease (colitis) kidney and liver diseases.
Avoid concomitant use of other antibiotics and diuretics along with CEFMAC TZ 562.5MG INJECTION. CEFMAC TZ 562.5MG INJECTION should be used with caution in pregnant and breast-feeding women. Consult your doctor before receiving the medicine.
CEFMAC TZ 562.5MG INJECTION should be used with caution in new-borns, children and adolescents. CEFMAC TZ 562.5MG INJECTION is not recommended for use in pre-mature babies and in children with or history of jaundice and hyperbilirubinemia. Consult your doctor before receiving the medicine.
CEFMAC TZ 562.5MG INJECTION should be used with caution in elderly people. The common side effect of receiving CEFMAC TZ 562.5MG INJECTION are diarrhoea, nausea, vomiting and skin allergies. Consult your doctor if any of the above side effects worsen or persist for a longer duration.